Advances in Cancer: Research & Treatment

Journal Information
ISSN / EISSN : 2326-702X / 2326-702X
Current Publisher: IBIMA Publishing (10.5171)
Total articles ≅ 24
Archived in
SHERPA/ROMEO
Filter:

Latest articles in this journal

Advances in Cancer: Research & Treatment; doi:10.5171/acrt

Abstract:
Peer-reviewed, open access journal that publishes original research articles, review articles, and case studies in all areas of cancer research and effective treatments.
Natalia Boroday, Vasily Chekhun, Ekaterina Golubeva, Dmitry Klyushin
Advances in Cancer: Research & Treatment pp 1-12; doi:10.5171/2016.706183

Taiichi Kodaka, Emiko Ishikawa Sakane, Hayato Maruoka, Hiroko Tsunemine, Hiroshi Akasaka, Kiminari Ito, Tetsuya Miura, Tomoo Itoh, Takayuki Takahashi
Advances in Cancer: Research & Treatment pp 1-12; doi:10.5171/2016.711926

Stoian Dana, Mihaela Craciunescu, Lazar Fulger, Diana Anastasiu, Marius Craina
Advances in Cancer: Research & Treatment pp 1-14; doi:10.5171/2014.515011

Eman El-Abd, Cecil Matta, Manal Sheta, Yasser El-Kerm, Mohammed Afifi, Traki Benhassine, Sarah Meftahi, Shimaa Sakr, Baseem Elsherbini
Advances in Cancer: Research & Treatment pp 1-19; doi:10.5171/2015.965854

Khalid Janbaz, Muhammad Ashfaq, Muhammad Qadir, Bashir Ahmad
Advances in Cancer: Research & Treatment pp 1-11; doi:10.5171/2014.900592

Sandeep Vishwakarma, Syed Paspala, Avinash Bardia, Santosh Tiwari, Aleem Khan
Advances in Cancer: Research & Treatment pp 1-18; doi:10.5171/2013.649799

Maria Skouroliakou, Ekaterini Vourvouhaki, Ioannis Tsamis, Marianna Sykara, Sofia Kyroudi-Markantoni, Dimitrios Pappas
Advances in Cancer: Research & Treatment pp 1-11; doi:10.5171/2013.260996

Abstract:
Until recently, anti-cancer clinics in order to plan and schedule chemotherapy treatments applied time-consuming methods, characterized by a high risk of error occurrence. Considering all the barriers that make chemotherapy treatment and demanding procedure, to evaluate if a chemotherapy management program could improve the administration of chemotherapy treatments. The authors developed “Carci”, a software tool designed to support anti-cancer clinics. The particular software program aims to provide an improved administration system for injectable anticancer agents and eliminate medication errors that could yield fatal events. The recording of patients’ data, the selection of the appropriate treatment protocol, the calculations of drug dosages, the correct preparation and administration of injectable solutions and the updating of secretariat, were conducted both manually and by using the computerized method. These two methods were compared and contrasted. The use of “Carci” resulted in a decrease in the time required to calculate patients’ Body Surface Area (BSA) and in a decrease in the occurrence of errors concerning the dosage of medication administered. A total of 18 patients with breast cancer were assigned to this pilot study. Significant differences were observed in BSA values (p=0.0391) and dosage (p=0.0042) between the computerized method “Carci” and manually by the doctor. Although this has been a pilot study, further evaluation of this software program in a larger sample of patients is required. Preliminary data, however, suggests that “Carci” can minimize the risk for error occurrence making chemotherapy treatment faster, easier and more accurate.
Jesus Del Pozo, Laura Rosende
Advances in Cancer: Research & Treatment pp 1-11; doi:10.5171/2013.442049

Back to Top Top